GO:0003720 telomerase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0003720 (telomerase activity) is a molecular_function defined as the catalysis of a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) = diphosphate + DNA(n+1) using an internal RNA template that encodes the telomeric repeat sequence.
Telomerase is a ribonucleoprotein reverse transcriptase that maintains telomere length and supports unlimited proliferative capacity in immortalised human cells.
Telomerase activity is detectable in most human cancers and is a recognised biomarker and therapeutic target for prostate cancer and other malignancies.
Lifestyle and psychological factors, including exercise training and stress, are associated with measurable changes in telomerase activity.
Pharmacological and nucleic-acid-based interventions can modulate telomerase activity, with implications for cancer and degenerative disease.
CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to establish causal roles of telomerase components in disease.

Description

Telomerase activity (GO:0003720) is the enzymatic function that adds telomeric DNA repeats to chromosome ends using an internal RNA template. This molecular_function is central to telomere maintenance, cellular immortalisation, and the proliferative capacity of stem and cancer cells. Because telomerase activity is absent or low in most normal somatic cells but frequently reactivated in tumours, it has become a major focus for cancer diagnostics and therapeutics. The term is also increasingly studied in ageing, degenerative disease, and lifestyle-related research. Understanding the precise catalytic mechanism, the genes encoding the telomerase complex, and the experimental methods used to measure telomerase activity is therefore essential for researchers across oncology, geroscience, and molecular biology.

telomerase activity At A Glance

GO ID GO:0003720
GO term telomerase activity
Ontology molecular_function
Synonym telomerase, catalyst; telomerase RNA reverse transcriptase activity
Definition Catalysis of the reaction: a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) = diphosphate + DNA(n+1) using an internal RNA template that encodes the telomeric repeat sequence.
Major function Elongation of telomeric DNA repeats at chromosome ends
Cofactor Divalent metal ions (e.g., Mg2+) required for reverse transcriptase catalysis
Substrate 2'-deoxyribonucleoside 5'-triphosphates (dNTPs) and a telomeric DNA primer
Template Internal telomerase RNA (TERC/TR) template region

What Is GO:0003720?

GO:0003720 (telomerase activity) describes the catalytic function of a ribonucleoprotein enzyme that synthesises telomeric DNA repeats. According to the QuickGO definition, it catalyses the reaction: a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) = diphosphate + DNA(n+1), using an internal RNA template that encodes the telomeric repeat sequence. In other words, telomerase is an RNA-dependent DNA polymerase (reverse transcriptase) that extends the 3' end of a DNA strand by copying a short template region within its own RNA subunit. This activity distinguishes telomerase from conventional DNA polymerases, which require a pre-existing DNA primer and cannot synthesise telomeric repeats de novo.

Why Is telomerase activity Important in Cell Biology?

Telomerase activity is important because it directly controls telomere length homeostasis, a process that determines replicative lifespan and genomic stability in eukaryotic cells. In vitro immortalised human cells depend on telomerase activity to maintain telomeres and bypass senescence. In clinical research, telomerase activity is a sensitive biomarker for circulating tumour cells and is being pursued as a therapeutic target in prostate cancer and other malignancies. Beyond cancer, telomerase activity is associated with psychological stress, mental disorders, lifestyle factors, and exercise interventions, making it relevant to ageing and degenerative disease research.
Maintains telomere length and supports unlimited proliferation in immortalised human cells.
Serves as a diagnostic and prognostic biomarker in circulating tumour cells and solid tumours.
Is a validated therapeutic target in prostate cancer prevention and treatment strategies.
Is modulated by pharmacological interventions with potential in cancer and degenerative disease.
Is influenced by exercise training, which increases TERT expression and telomerase activity.
Is associated with psychological stress, mental disorders, and lifestyle factors.
Can be activated by circular RNAs such as circHERC1-A, revealing new regulatory layers.
Provides a mechanistic link between telomere maintenance and cellular ageing.
Enables researchers to study reverse transcriptase mechanism using an internal RNA template.
Underpins CRISPR-based disease modelling of telomerase-related pathologies.

What Happens During telomerase activity?

Template recognition and primer binding
In simple terms: Telomerase first grabs the chromosome end and lines it up with its own RNA template.
Telomerase is a ribonucleoprotein complex in which the RNA subunit (TERC/TR) contains a template region complementary to the telomeric repeat. The enzyme binds the 3' overhang of the telomeric DNA primer and aligns it with the template, positioning the catalytic site for nucleotide addition. This step is essential for the subsequent elongation reaction and is regulated by accessory proteins.
Catalytic addition of telomeric repeats
In simple terms: The enzyme then adds DNA letters one by one, copying its RNA template.
Using the internal RNA template, telomerase catalyses the addition of 2'-deoxyribonucleoside 5'-triphosphates to the DNA primer, releasing diphosphate and extending the DNA by one nucleotide at a time. This reverse transcriptase activity is processive and can add multiple telomeric repeats before translocation. The reaction requires divalent metal ions and is distinct from canonical DNA polymerase activity.
Translocation and repeat synthesis
In simple terms: After copying one repeat, the enzyme shifts and starts again to make many repeats.
Following synthesis of one telomeric repeat, telomerase translocates along the DNA primer to realign the template for the next round of repeat addition. This iterative process generates long telomeric tracts and is a hallmark of telomerase activity. The efficiency of translocation contributes to overall enzyme processivity and telomere elongation capacity.
Regulation by telomerase-associated proteins
In simple terms: Other proteins help or restrain telomerase so it works at the right time and place.
Telomerase activity is regulated by accessory factors that control assembly, recruitment to telomeres, and catalytic efficiency. For example, dyskerin and other H/ACA ribonucleoprotein components stabilise the RNA subunit, while shelterin proteins regulate access to chromosome ends. Pharmacological and nucleic-acid interventions can modulate telomerase activity, highlighting its druggability.
Telomere maintenance and cellular outcomes
In simple terms: The final result is longer telomeres, which helps cells keep dividing.
The net outcome of telomerase activity is telomere elongation, which counteracts replicative shortening and supports continued cell division. In vitro immortalised human cells rely on telomerase activity for telomere maintenance and indefinite proliferation. In cancer cells, this activity contributes to tumour growth and is a target for therapeutic intervention.

Key Genes Involved in GO:0003720 telomerase activity

The following genes and proteins are central to telomerase activity, its regulation, and its measurement in research and clinical settings.
GeneMajor RoleResearch Relevance
TERTCatalytic reverse transcriptase subunit of telomeraseCore enzyme for telomerase activity assays and CRISPR knockout studies
TERCRNA subunit providing the template for telomeric repeatsEssential for reconstitution and mutational analysis of telomerase
DKC1Dyskerin, stabilises telomerase RNA and H/ACA RNP assemblyLinks telomerase to dyskeratosis congenita and ribosomopathy research
NOP10H/ACA RNP component required for telomerase RNA stabilityModel for telomerase assembly defects
NHP2H/ACA RNP component involved in telomerase RNA processingStudied in telomere maintenance disorders
GAR1H/ACA RNP component aiding telomerase RNA maturationRelevant to telomerase biogenesis
POT1Shelterin component regulating telomere accessModulates telomerase recruitment to chromosome ends
TPP1Shelterin component that recruits telomerase to telomeresKey regulator of telomerase activity in vivo
TRF1Shelterin component controlling telomere lengthNegative regulator of telomerase-dependent elongation
TRF2Shelterin component protecting telomere endsPrevents inappropriate telomerase access
RAP1Shelterin-associated protein involved in telomere protectionStudied in telomere length homeostasis
circHERC1-ACircular RNA that activates telomeraseEmerging activator of telomerase activity
TEP1Telomerase-associated protein involved in RNP assemblyModel for telomerase complex composition
HSP90Chaperone supporting telomerase assembly and activityPharmacological target for telomerase modulation
p23Co-chaperone assisting telomerase maturationStudied in telomerase assembly pathways
Ku70/Ku80DNA repair proteins with telomeric functionsCrosstalk between telomerase and DNA repair
ATMDNA damage kinase influencing telomere maintenanceLinks telomerase activity to genome stability

How Is telomerase activity Regulated?

Telomerase activity is regulated at multiple levels, including transcription of TERT, assembly and stability of the telomerase RNP, recruitment to telomeres by shelterin proteins, and post-translational modifications. Pharmacological interventions can directly or indirectly affect telomerase activity, offering strategies for cancer and degenerative disease. Exercise training has been shown to increase TERT gene expression and telomerase activity in systematic reviews and meta-analyses. Psychological stress, mental disorders, and lifestyle factors are also associated with altered telomerase activity. Circular RNAs such as circHERC1-A can act as telomerase activators, adding a new layer of regulation.

telomerase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
TERTCancer, telomere biology disordersCRISPR knockout and point-mutation cell lines
TERCDyskeratosis congenita, aplastic anaemiaKnock-in of patient mutations in haematopoietic cells
DKC1Dyskeratosis congenita, ribosomopathyKnockout and knock-in models in fibroblasts
POT1Telomere protection defects, melanomaPoint-mutation knock-in in cancer cell lines
TPP1Telomere recruitment defectsOverexpression and knockout models
Cancer and telomerase reactivation
Telomerase activity is frequently reactivated in human cancers and supports unlimited proliferation. In prostate cancer, modulation of telomerase activity is being explored for prevention and treatment. Sensitive detection of telomerase activity in circulating tumour cells offers a liquid-biopsy approach for cancer monitoring. Pharmacological inhibition of telomerase is a promising anticancer strategy.
Degenerative disease and ageing
Reduced telomerase activity is associated with telomere shortening and degenerative phenotypes. Pharmacological strategies to enhance telomerase activity are being investigated for degenerative disease. Lifestyle interventions such as exercise training can increase telomerase activity and may benefit ageing-related outcomes.
Psychological stress and mental disorders
A systematic review found associations between telomerase activity and psychological stress, mental disorders, and lifestyle factors. These findings suggest telomerase activity as a biomarker and potential intervention target in stress-related conditions.
Ribosomopathy and telomere biology disorders
Mutations in telomerase RNA processing factors such as DKC1 cause dyskeratosis congenita, a ribosomopathy with defective telomere maintenance. These disorders highlight the importance of telomerase RNP assembly for human health.

From telomerase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Is TERT required for telomerase activity?TERT knockout cell line
Does a specific TERT mutation affect catalysis?Point-mutation knock-in of TERT
Can a disease-associated TERC variant impair telomerase?Knock-in of TERC mutant alleles
Where does telomerase localise in cells?Tagged knock-in of TERT or TERC
Does overexpression of circHERC1-A increase telomerase activity?Overexpression of circHERC1-A
Can telomerase activity be detected in circulating tumour cells?Patient-derived CTC models

How to Study the telomerase activity Process

MethodWhat It MeasuresTypical Application
TRAP assayTelomerase enzymatic activityCancer diagnostics and drug screening
RT-qPCRTERT and TERC mRNA levelsGene expression studies
RNA-seqTranscriptome changesPathway analysis of telomerase regulation
Western blotProtein expression of telomerase subunitsValidation of knockout or overexpression
ImmunoprecipitationProtein-protein interactions in telomerase RNPComplex assembly studies
Mass spectrometryTelomerase-associated proteinsDiscovery of new regulators
Fluorescence imagingTelomerase activity in single cellsCirculating tumour cell detection
Telomerase activity assays
The telomeric repeat amplification protocol (TRAP) and its high-fidelity variants measure telomerase activity by detecting telomeric repeat synthesis. These assays are used in cancer diagnostics and drug discovery.
Gene expression analysis
RT-qPCR and RNA-seq are used to measure TERT and TERC expression, which correlate with telomerase activity. Systematic reviews have used these methods to link exercise training to increased TERT expression.
Protein and RNP analysis
Immunoprecipitation, western blotting, and mass spectrometry can characterise telomerase complex components and assembly. These methods help identify accessory factors and post-translational modifications.
Imaging and single-cell approaches
Fluorescence imaging and single-cell assays enable detection of telomerase activity in circulating tumour cells and rare cell populations. These approaches support liquid biopsy and minimal residual disease monitoring.

How CRISPR Can Be Used to Study GO:0003720 telomerase activity

Knockout

CRISPR knockout of TERT or TERC abolishes telomerase activity and causes progressive telomere shortening, providing a clean model to study loss-of-function phenotypes. Knockout of accessory genes such as DKC1 reveals assembly defects.

Point Mutation

Point-mutation knock-in of catalytic residues in TERT or template mutations in TERC allows precise dissection of the reverse transcriptase mechanism. These models are valuable for testing disease-associated variants.

Knock-in

Knock-in of tagged TERT or TERC enables localisation and interaction studies without altering catalytic activity. Disease-relevant mutations can be introduced to model telomere biology disorders.

Overexpression

Overexpression of TERT or activating circular RNAs such as circHERC1-A increases telomerase activity and can be used to study telomere elongation and cellular immortalisation. Overexpression models are also useful for drug screening.

How EDITGENE Supports telomerase activity Research

Researchers studying telomerase activity-related genes often need to determine whether a candidate gene is causally involved in telomere maintenance, cancer progression, or degenerative disease. Establishing causality requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides end-to-end CRISPR services to generate such models and to support downstream functional and bioinformatic analysis.
Contact EDITGENE today to design your custom CRISPR model for telomerase activity research.

Frequently Asked Questions About telomerase activity

Telomerase activity is the molecular function that catalyses the addition of telomeric DNA repeats using an internal RNA template, as defined by GO:0003720.
Key genes include TERT (catalytic subunit), TERC (RNA template), and accessory factors such as DKC1, NOP10, NHP2, GAR1, and shelterin components.
The TRAP assay and its high-fidelity variants are standard methods for measuring telomerase enzymatic activity.
Telomerase activity supports unlimited proliferation in cancer cells and is a target for diagnosis and therapy.
A systematic review and meta-analysis found that exercise training increases TERT expression and telomerase activity.
Cancer, degenerative disease, dyskeratosis congenita, and stress-related mental disorders have been associated with altered telomerase activity.
TERT is the catalytic reverse transcriptase subunit that synthesises telomeric repeats using the TERC template.
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of telomerase-related genes.
circHERC1-A is a circular RNA that acts as a telomerase activator, increasing telomerase activity.
Pharmacological intervention strategies targeting telomerase activity are being developed for cancer and degenerative disease.

Conclusion

Telomerase activity (GO:0003720) is a fundamental molecular function that maintains telomeres and supports cellular immortalisation, with broad implications for cancer, ageing, and degenerative disease. Its regulation by genetic, pharmacological, and lifestyle factors makes it a rich area for research. CRISPR-based models and advanced detection methods are accelerating the translation of telomerase biology into clinical applications.

References

  1. 1. Zvereva MI et al.. 2010. Telomerase: structure, functions, and activity regulation.. Biochemistry (Mosc) 75(13):1563-83 PMID: 21417995
  2. 2. Cui Y et al.. 2025. circHERC1-A telomerase activator.. Sci Adv 11(46):eadz3680 PMID: 41223261
  3. 3. Deng W et al.. 2016. Telomerase activity and its association with psychological stress, mental disorders, lifestyle factors and interventions: A systematic review.. Psychoneuroendocrinology 64:150-63 PMID: 26677763
  4. 4. Kim NW et al.. 2001. Telomerase activity modulation in the prevention of prostate cancer.. Urology 57(4 Suppl 1):148-53 PMID: 11295615
  5. 5. Denham J et al.. 2021. Exercise training increases telomerase reverse transcriptase gene expression and telomerase activity: A systematic review and meta-analysis.. Ageing Res Rev 70:101411 PMID: 34284150
  6. 6. Wang Z et al.. 2024. High-Fidelity Sensitive Tracing Circulating Tumor Cell Telomerase Activity.. Anal Chem 96(14):5527-5536 PMID: 38483815
  7. 7. Bryan TM et al.. 1997. Telomere dynamics and telomerase activity in in vitro immortalised human cells.. Eur J Cancer 33(5):767-73 PMID: 9282115
  8. 8. Tárkányi I et al.. 2008. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.. Biochimie 90(1):156-72 PMID: 17945408
Contact Us
*
*
*
*
How did you hear about us: